Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1368–1371. doi: 10.1054/bjoc.2001.2093

Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases

A Figer 1, R Shtoyerman-Chen 2, A Tamir 5, R Geva 1, L Irmin 1,4, D Flex 1, L Theodor 2, A Sulkes 1, S Sadetzki 3, S Bar-Meir 2, E Friedman 4
PMCID: PMC2375261  PMID: 11720476

Abstract

The I1307K APC germline mutation is associated with an increased risk to colo-rectal cancer (CRC). Whether and to what extent the phenotype of CRC in mutation carriers differs from sporadic cases, remains unknown. To gain insight into this issue, we analysed 307 unselected Israeli patients with CRC, who were treated in a single medical centre, for harbouring the I1307K mutation. Twenty-eight mutation carriers (9.1%) were detected. Two of 28 mutation carriers (7.1%) and 93/277 (33.6%) of non-carriers, were of non-Ashkenazi origin (P< 0.01). In 74/278 (26.6%) of the sporadic cases, and only 1/28 (3.6%) of mutation carriers (3.6%) the tumour was located in the right colon (P< 0.01). Mutation carriers had a more advanced disease stage (14/28 – 50% Dukes C), as compared with 60 (19.5%) of non-carriers (P= 0.02). The mean age at diagnosis was similar: 65 (+/– 9.7) years and 66.3 (+/– 11.6) years, for mutation carriers and non-carriers, respectively. No statistical differences were noted between the two groups in sex distribution, tumour grade, and family history of cancer. We conclude that early age at diagnosis and family history of cancer cannot be used to predict who is likely to harbour the I1307K APC germline mutation carriers. However, the tumours in patients with this mutation appear different than those without, are less likely to be proximal and more likely to be advanced than tumours in non-carriers.   http://www.bjcancer.com © 2001 Cancer Research Campaign

Keywords: inherited predisposition to cancer, I1307K APC mutation, phenotype

Full Text

The Full Text of this article is available as a PDF (50.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Drucker L., Shpilberg O., Neumann A., Shapira J., Stackievicz R., Beyth Y., Yarkoni S. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype. Cancer. 2000 Feb 15;88(4):755–760. [PubMed] [Google Scholar]
  2. Gryfe R., Di Nicola N., Lal G., Gallinger S., Redston M. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet. 1999 Feb;64(2):378–384. doi: 10.1086/302262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Laken S. J., Petersen G. M., Gruber S. B., Oddoux C., Ostrer H., Giardiello F. M., Hamilton S. R., Hampel H., Markowitz A., Klimstra D. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997 Sep;17(1):79–83. doi: 10.1038/ng0997-79. [DOI] [PubMed] [Google Scholar]
  4. Nathanson K. L., Antin-Ozerkis D., Couch F. J., Weber B. L. I1307K APC variant in non-Ashkenazi Jewish women affected with breast cancer. Am J Med Genet. 1999 Jul 16;85(2):189–190. [PubMed] [Google Scholar]
  5. Patael Y., Figer A., Gershoni-Baruch R., Papa M. Z., Risel S., Shtoyerman-Chen R., Karasik A., Theodor L., Friedman E. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. Eur J Hum Genet. 1999 Jul;7(5):555–559. doi: 10.1038/sj.ejhg.5200325. [DOI] [PubMed] [Google Scholar]
  6. Prior T. W., Chadwick R. B., Papp A. C., Arcot A. N., Isa A. M., Pearl D. K., Stemmermann G., Percesepe A., Loukola A., Aaltonen L. A. The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology. 1999 Jan;116(1):58–63. doi: 10.1016/s0016-5085(99)70229-5. [DOI] [PubMed] [Google Scholar]
  7. Rozen P., Shomrat R., Strul H., Naiman T., Karminsky N., Legum C., Orr-Urtreger A. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology. 1999 Jan;116(1):54–57. doi: 10.1016/s0016-5085(99)70228-3. [DOI] [PubMed] [Google Scholar]
  8. Shtoyerman-Chen R., Friedman E., Figer A., Carmel M., Patael Y., Rath P., Fidder H. H., Bar-Meir S., Theodor L. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Genet Test. 2001 Summer;5(2):141–146. doi: 10.1089/109065701753145628. [DOI] [PubMed] [Google Scholar]
  9. Stern H. S., Viertelhausen S., Hunter A. G., O'Rourke K., Cappelli M., Perras H., Serfas K., Blumenthall A., Dewar D., Baumann E. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews. Gastroenterology. 2001 Feb;120(2):392–400. doi: 10.1053/gast.2001.21170. [DOI] [PubMed] [Google Scholar]
  10. Syngal S., Schrag D., Falchuk M., Tung N., Farraye F. A., Chung D., Wright M., Whetsell A., Miller G., Garber J. E. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000 Aug 16;284(7):857–860. doi: 10.1001/jama.284.7.857. [DOI] [PubMed] [Google Scholar]
  11. Woodage T., King S. M., Wacholder S., Hartge P., Struewing J. P., McAdams M., Laken S. J., Tucker M. A., Brody L. C. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet. 1998 Sep;20(1):62–65. doi: 10.1038/1722. [DOI] [PubMed] [Google Scholar]
  12. Yuan Z. Q., Kasprzak L., Gordon P. H., Pinsky L., Foulkes W. D. I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer. Clin Genet. 1998 Oct;54(4):368–370. doi: 10.1034/j.1399-0004.1998.5440421.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES